Artal Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $166K | Hold |
|
|||||
|
2023
Q2 | $178K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $87.5M | Sell |
|
|||||
|
2022
Q1 | $106M | Hold |
|
|||||
|
2021
Q4 | $110M | Sell |
|
|||||
|
2021
Q3 | $132M | Sell |
|
|||||
|
2021
Q2 | $127M | Hold |
|
|||||
|
2021
Q1 | $106M | Sell |
|
|||||
|
2020
Q4 | $104M | Hold |
|
|||||
|
2020
Q3 | $116M | Sell |
|
|||||
|
2020
Q2 | $133M | Sell |
|
|||||
|
2020
Q1 | $120M | Buy |
|
|||||
|
2019
Q4 | $115M | Buy |
|
|||||
|
2019
Q3 | $56.3M | Buy |
|
|||||
|
2019
Q2 | $29M | Sell |
|
|||||
|
2019
Q1 | $42.1M | Sell |
|
|||||
|
2018
Q4 | $36.5M | Sell |
|
|||||
|
2018
Q3 | $52.5M | Sell |
|
|||||
|
2018
Q2 | $64M | Buy |
|
|||||
|
2018
Q1 | $71.5M | Buy |
|
|||||
|
2017
Q4 | $57.2M | Buy |
|
|||||
|
2017
Q3 | $29.4M | Sell |
|
|||||
|
2017
Q2 | $21.9M | Sell |
|
|||||
|
2017
Q1 | $15.4M | Sell |
|
|||||
|
2016
Q4 | $18.7M | Sell |
|
|||||
|
2016
Q3 | $40.7M | Sell |
|
|||||
|
2016
Q2 | $39.4M | Buy |
|
|||||
|
2016
Q1 | $37.7M | Buy |
|
|||||
|
2015
Q4 | $44.7M | Buy |
|
|||||
|
2015
Q3 | $35M | Sell |
|
|||||
|
2015
Q2 | $54.5M | Sell |
|
|||||
|
2015
Q1 | $49.1M | Buy |
|
|||||
|
2014
Q4 | $38.8M | Buy |
|
|||||
|
2014
Q3 | $23.4M | Hold |
|
|||||
|
2014
Q2 | $19M | Buy |
|
|||||
|
2014
Q1 | $13.8M | Buy |
|
|||||
|
2013
Q4 | $8.04M | Buy |
|